KP
1. Describe your assigned client’s situation. Why are they presenting to the clinic? What medications are they currently taking?
Gabriel Contreras is a 31-year-old transgender male (he/him) who presents to the clinic to discuss gender-affirming hormone therapy for gender dysphoria. He has lived as male for five years and wants testosterone to develop male secondary sex characteristics. He prefers a topical formulation. He currently takes no medications, has no past medical history or allergies, never smoked, and drinks alcohol twice a month. Vital signs and physical exam are unremarkable (BMI 26.8).
2. Discuss your personal professional assessment of the client’s situation provided in the scenario. What pharmacological treatment is necessary and why?
Gender-affirming testosterone therapy is appropriate for this adult client who meets clinical criteria and has a clear preference for topical treatment. Transdermal testosterone (patch or gel) is a reasonable first-line option because it provides steady hormone levels, avoids injections, and aligns with patient preference. The prescription of testosterone transdermal patch 2 mg (two patches daily) is consistent with available dosing ranges and accounts for body composition. Topical formulations can produce masculinizing effects, though menstrual cessation may occur more gradually than with injectable forms. Patient education on proper application, skin transfer risk, and expected timelines is essential, along with monitoring for adverse effects (such as polycythemia, acne, and/or lipid changes).
3. Reflect on additional questions you have about your assigned client that may influence treatment. What else do you want to know? What follow-up assessments, labs, or conversations are required to ensure optimal health outcomes?
Key information still needed includes fertility goals and desire for gamete preservation, current menstrual status and any prior hormone exposure, mental-health support and capacity for informed consent, and any family history of cardiovascular disease, polycythemia, or hormone-sensitive cancers. Baseline labs should include total and free testosterone, estradiol, complete blood count (especially hematocrit), liver enzymes, fasting lipids, and metabolic panels (Dimakopoulou & Seal, 2024). Follow-up is recommended at three months and periodically thereafter to check hormone levels, hematocrit, lipids, blood pressure, and clinical response, with dose adjustment as needed. Ongoing conversation should address realistic expectations for timeline of physical changes, skin care with topical products, and long-term health maintenance to ensure optimal health outcomes.
References
Dimakopoulou, A., & Seal, L. J. (2024). Testosterone and other treatments for transgender males and non-binary trans masculine individuals. Best Practice & Research Clinical Endocrinology & Metabolism, 38(5), 101908. https://10.1016/j.beem.2024.101908Links to an external site.
Needs help with similar assignment?
We are available 24x7 to deliver the best services and assignment ready within 3-4 hours? Order a custom-written, plagiarism-free paper

